Magnetic resonance imaging techniques for monitoring glioma response to chemoradiotherapy
Abstract
Purpose Treatment response assessment for gliomas currently uses changes in tumour size as measured with T 1 - and T 2 -weighted MRI. However, changes in tumour size may occur many weeks after therapy completion and are confounded by radiation treatment effects. Advanced MRI techniques sensitive to tumour physiology may provide complementary information to evaluate tumour response at early timepoints during therapy. The objective of this review is to provide a summary of the history and current knowledge regarding advanced MRI techniques for early treatment response evaluation in glioma. Methods The literature survey included perfusion MRI, diffusion-weighted imaging, quantitative magnetization transfer imaging, and chemical exchange transfer MRI. Select articles spanning the history of each technique as applied to treatment response evaluation in glioma were chosen. This report is a narrative review, not formally systematic. Results Chemical exchange saturation transfer imaging potentially offers the earliest method to detect tumour response due to changes in metabolism. Diffusion-weighted imaging is sensitive to changes in tumour cellularity later during radiotherapy and is prognostic for progression-free and overall survival. Substantial evidence suggests that perfusion MRI can differentiate between tumour recurrence and treatment effect, but consensus regarding acquisition, processing, and interpretation is still lacking. Magnetization transfer imaging shows promise for d…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
No single diffusion marker can reliably distinguish viable tumor from pseudo-progression or radiation necrosis.
“no single diffusion marker can reliably distinguish viable tumor from pseudo-progression or radiation necrosis (Lawrence et al., 2025).”
From 40 Years of diffusion MRI in the brain: From history to emerging frontiers (2026) · cites this paper as Lawrence et al., 2025
Cited by
Sorted by citations
40 Years of diffusion MRI in the brain: From history to emerging frontiers
Le Bihan, D. (2026) · Imaging Neuroscience · doi:10.1162/imag.a.1365
“Diffusion Diffusion MRI may also provide complementary information for treatment monitoring, but no single diffusion marker can reliably distinguish viable tumor from pseudo-progression or radiation necrosis ( Lawrence et al., 2025).”
- Authors
- Lawrence, L. S. P., Maralani, P. J., Das, S., Sahgal, A., Stanisz, G. J., & Lau, A. Z.
- Affiliations
- University of Toronto (CA)
- Sunnybrook Health Science Centre (CA)
- St. Michael's Hospital (CA)
- Medical University of Lublin (PL)
- Corresponding author
- Lau, Angus Z.
- Venue
- Journal of Neuro-Oncology
- Published
- 2024-11-11
- Volume
- 171
- Issue
- 2
- Pages
- 255-264
- ISSN
- 0167-594X (ISSN-L)
- 1573-7373
- OpenAlex
- W4404233593
- Cited by
- 4
- References
- 0
- Citations by year
- 2026: 2 · 2025: 2
- FWCI
- 0.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Journal of Neuro-Oncology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Natural Sciences and Engineering Research Council of Canada (CGS-D program, RGPIN-2017-06596)
- Canadian Institutes of Health Research (PJT-148660, PJT-180272, 175081)
- Terry Fox Research Institute (115-03, TFRI project 1034)
- Terry Fox Foundation (New Frontiers Program Project Grant)
- Topics
- Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Keywords
- glioma, chemoradiotherapy, treatment response monitoring, early response assessment, perfusion MRI, diffusion-weighted imaging, chemical exchange saturation transfer imaging, tumor cellularity, tumor recurrence, white matter injury, tumor invasion, multiparametric imaging, cancer metabolism
- MeSH terms
- Brain Neoplasms, Glioma, Humans, Magnetic Resonance Imaging, Chemoradiotherapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review